Ellen Zwarthoff
Ellen Zwarthoff
hoogleraar moleculaire pathologie, Erasmus MC Rotterdam
Verified email at erasmusmc.nl - Homepage
Title
Cited by
Cited by
Year
Benefit of abciximab in patients with refractory unstable angina in relation to serum troponin T levels
CW Hamm, C Heeschen, B Goldmann, A Vahanian, J Adgey, CM Miguel, ...
New England Journal of Medicine 340 (21), 1623-1629, 1999
890*1999
The immune landscape of cancer
V Thorsson, DL Gibbs, SD Brown, D Wolf, DS Bortone, THO Yang, ...
Immunity 48 (4), 812-830. e14, 2018
8472018
Comprehensive molecular characterization of muscle-invasive bladder cancer
AG Robertson, J Kim, H Al-Ahmadie, J Bellmunt, G Guo, AD Cherniack, ...
Cell 171 (3), 540-556. e25, 2017
7642017
Comprehensive characterization of cancer driver genes and mutations
MH Bailey, C Tokheim, E Porta-Pardo, S Sengupta, D Bertrand, ...
Cell 173 (2), 371-385. e18, 2018
6982018
Oncogenic signaling pathways in the cancer genome atlas
F Sanchez-Vega, M Mina, J Armenia, WK Chatila, A Luna, KC La, ...
Cell 173 (2), 321-337. e10, 2018
5952018
Cell-of-origin patterns dominate the molecular classification of 10,000 tumors from 33 types of cancer
KA Hoadley, C Yau, T Hinoue, DM Wolf, AJ Lazar, E Drill, R Shen, ...
Cell 173 (2), 291-304. e6, 2018
5242018
Efficient rescue of integrated shuttle vectors from transgenic mice: a model for studying mutations in vivo
JA Gossen, WJ De Leeuw, CH Tan, EC Zwarthoff, F Berends, PH Lohman, ...
Proceedings of the National Academy of Sciences 86 (20), 7971-7975, 1989
5231989
An integrated TCGA pan-cancer clinical data resource to drive high-quality survival outcome analytics
J Liu, T Lichtenberg, KA Hoadley, LM Poisson, AJ Lazar, AD Cherniack, ...
Cell 173 (2), 400-416. e11, 2018
4962018
The fibroblast growth factor receptor 3 (FGFR3) mutation is a strong indicator of superficial bladder cancer with low recurrence rate
BWG van Rhijn, I Lurkin, F Radvanyi, WJ Kirkels, TH van der Kwast, ...
Cancer research 61 (4), 1265-1268, 2001
3442001
Impact of molecular subtypes in muscle-invasive bladder cancer on predicting response and survival after neoadjuvant chemotherapy
R Seiler, HAD Ashab, N Erho, BWG van Rhijn, B Winters, J Douglas, ...
European urology 72 (4), 544-554, 2017
3272017
Molecular grading of urothelial cell carcinoma with fibroblast growth factor receptor 3 and MIB-1 is superior to pathologic grade for the prediction of clinical outcome
BWG van Rhijn, AN Vis, TH van der Kwast, WJ Kirkels, F Radvanyi, ...
Journal of clinical oncology 21 (10), 1912-1921, 2003
3222003
FGFR3, HRAS, KRAS, NRAS and PIK3CA mutations in bladder cancer and their potential as biomarkers for surveillance and therapy
LC Kompier, I Lurkin, MNM van der Aa, BWG van Rhijn, TH van der Kwast, ...
PloS one 5 (11), e13821, 2010
2822010
Translocation (12; 22)(p13; q11) in myeloproliferative disorders results in fusion of the ETS-like TEL gene on 12p13 to the MN1 gene on 22q11
AJ Buijs, S Sherr, S Baal, S Bezouw, DC van der Plas, ...
2821995
Comprehensive transcriptional analysis of early-stage urothelial carcinoma
J Hedegaard, P Lamy, I Nordentoft, F Algaba, S Hyer, BP Ulhi, S Vang, ...
Cancer cell 30 (1), 27-42, 2016
2762016
Distinct gene mutation profiles among luminal-type and basal-type breast cancer cell lines
A Hollestelle, JHA Nagel, M Smid, S Lam, F Elstrodt, M Wasielewski, ...
Breast cancer research and treatment 121 (1), 53-64, 2010
2592010
Machine learning identifies stemness features associated with oncogenic dedifferentiation
TM Malta, A Sokolov, AJ Gentles, T Burzykowski, L Poisson, JN Weinstein, ...
Cell 173 (2), 338-354. e15, 2018
2462018
FGFR3 and P53 characterize alternative genetic pathways in the pathogenesis of urothelial cell carcinoma
BWG van Rhijn, TH van der Kwast, AN Vis, WJ Kirkels, ER Boev, ...
Cancer research 64 (6), 1911-1914, 2004
2462004
The cancer genome atlas comprehensive molecular characterization of renal cell carcinoma
CJ Ricketts, AA De Cubas, H Fan, CC Smith, M Lang, E Reznik, R Bowlby, ...
Cell reports 23 (1), 313-326. e5, 2018
2342018
Genomic and molecular landscape of DNA damage repair deficiency across The Cancer Genome Atlas
TA Knijnenburg, L Wang, MT Zimmermann, N Chambwe, GF Gao, ...
Cell reports 23 (1), 239-254. e6, 2018
2212018
Pathogenic germline variants in 10,389 adult cancers
K Huang, RJ Mashl, Y Wu, DI Ritter, J Wang, C Oh, M Paczkowska, ...
Cell 173 (2), 355-370. e14, 2018
2182018
The system can't perform the operation now. Try again later.
Articles 1–20